Readystate Asset Management’s Pfizer PFE Stock Holding History

Readystate Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$870K	Buy	+31,000	New	+$825K	0.04%	259
2025 Q2	–	Sell	-75,700	Closed	-$1.92M	–	866
2025 Q1	$1.92M	Sell	75,700 -16,600	-18%	-$434K	0.06%	328
2024 Q4	$2.45M	Sell	92,300 -407,000	-82%	-$11M	0.08%	268
2024 Q3	$14.4M	Buy	499,300 +475,500	+1,998%	+$13.9M	0.27%	125
2024 Q2	$666K	Sell	23,800 -614,600	-96%	-$16.9M	0.02%	433
2024 Q1	$17.7M	Buy	638,400 +632,100	+10,033%	+$17.5M	0.25%	64
2023 Q4	$181K	Buy	+6,300	New	+$190K	0.01%	537
2023 Q2	–	Sell	-7,600	Closed	-$310K	–	388
2023 Q1	$310K	Buy	+7,600	New	+$328K	0.03%	244

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Readystate Asset Management's PFE Position: Q1 2025 in Review

Readystate Asset Management sold out of Pfizer (PFE) in Q1 2025, closing a stake of 39,346 shares — an estimated $1.03M sold.

Readystate Asset Management first reported a position in PFE in Q4 2024 and held it in 1 quarter. The position peaked at $1.04M in Q4 2024. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Readystate Asset Management reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
Readystate Asset Management sold 39,346 Pfizer shares in Q1 2025, an estimated $1.03M.
Readystate Asset Management first reported a position in Pfizer in Q4 2024 and held it in 1 quarter.
Readystate Asset Management's Pfizer position peaked at $1.04M in Q4 2024.
2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Readystate Asset Management's 13F filing for Q1 2025, filed 6 May 2025.